These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1201420)

  • 1. Proceedings: Biochemical evidence for the involvement of noradrenaline in motor activity produced by L-DOPA in rodents.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Oct; 55(2):292P. PubMed ID: 1201420
    [No Abstract]   [Full Text] [Related]  

  • 2. Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activity.
    Dolphin A; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Oct; 5(4):431-9. PubMed ID: 1005491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A; Jenner P; Marsden CD
    Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract]   [Full Text] [Related]  

  • 4. Locomotor stimulation by L-dopa: relative importance of noradrenaline receptor activation.
    Andén NE; Strömbom U; Svensson TH
    Psychopharmacology (Berl); 1977 Nov; 54(3):243-8. PubMed ID: 413140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Influence of H44/68 and FLA63 on central catecholamines and motor activity under light and darkness.
    Lemmer B; Berger T
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R13. PubMed ID: 238144
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of cerebral noradrenaline and dopamine depletion on spontaneous and amphetamine-stimulated motor activity in rats].
    Romero Vecchione E; Saturno N; Campos HA
    Acta Cient Venez; 1989; 40(2):113-8. PubMed ID: 2640764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple quantitative bradykinesia test in MPTP-treated mice.
    Ogawa N; Hirose Y; Ohara S; Ono T; Watanabe Y
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):435-41. PubMed ID: 3878557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The irritant properties of dopamine-beta-hydroxylase inhibitors in relation to their effects on L-dopa-induced locomotor activity.
    Dolphin A; Elliott PN; Jenner P
    J Pharm Pharmacol; 1976 Oct; 28(10):782-5. PubMed ID: 10378
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-aggressive action of dopamine-beta-hydroxylase inhibitors in mice.
    Ross SB; Ogren SO
    J Pharm Pharmacol; 1976 Jul; 28(7):590-2. PubMed ID: 8618
    [No Abstract]   [Full Text] [Related]  

  • 11. Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase.
    Dolphin A; Jenner P; Marsden CD
    Eur J Pharmacol; 1976 Jan; 35(1):135-44. PubMed ID: 1253815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.
    Berger T; Lemmer B
    Pol J Pharmacol Pharm; 1976; 28(6):601-3. PubMed ID: 1012983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
    Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of the dopamine and noradrenaline systems in regulating autogenic motor activity in rat pups].
    Timofeeva OP
    Zh Evol Biokhim Fiziol; 1989; 25(1):123-5. PubMed ID: 2728686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine hypothermia and brain nicotine and catecholamine levels in the mouse.
    Mansner R; Alhava E; Klinge E
    Med Biol; 1974 Dec; 52(6):390-8. PubMed ID: 4444360
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of simultaneous administration of 3,4-dihydroxyphenylpyruvic acid and L-dopa on the bioavailability of L-dopa in rat and mouse.
    Hietala P; Lindén IB; Grönfors N
    J Pharm Pharmacol; 1979 Apr; 31(4):205-8. PubMed ID: 36456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 18. Central action of narcotic analgesics. Part III. The role of endogenous noradrenaline in hyperactivity induced by morphine or fentanyl in mice.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1978; 30(4):537-47. PubMed ID: 216979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-DOPA attenuates hyperactivity of Roborovskii hamsters.
    Kabuki Y; Shigemi K; Hamasu K; Furuse M
    Behav Pharmacol; 2009 May; 20(3):260-4. PubMed ID: 19404194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha1-adrenoceptors mediate dihydroxyphenylalanine-induced activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaques.
    Visanji NP; Fox SH; Johnston TH; Millan MJ; Brotchie JM
    J Pharmacol Exp Ther; 2009 Jan; 328(1):276-83. PubMed ID: 18955589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.